Predictors of ICU outcome with Lactate Concentration, Base Excess and Alactic Base Excess (ABE) as in patients with sepsis and septic shock
Not Applicable
- Conditions
- Health Condition 1: E874- Mixed disorder of acid-base balance
- Registration Number
- CTRI/2024/08/072558
- Lead Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age more than 18 years
Patients with sepsis or septic shock
Acute kidney injury stage I and II
Exclusion Criteria
AKI stage III
AKI on RRT
CKD patients eGFR less than 60
Patients on diuretic therapy at admission
Post renal transplant patients
Expected stay in ICU less than 72 hours
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do lactate and alactic base excess (ABE) correlate with pathophysiological pathways in sepsis-induced acid-base disorders?
Does alactic base excess (ABE) outperform standard lactate levels in predicting ICU mortality in septic shock patients?
Which acid-base parameters (lactate, base excess, ABE) best predict ICU outcomes in patients with E874 mixed acid-base disorders?
What management strategies are effective for acid-base imbalances in sepsis patients with elevated lactate and ABE?
How does alactic base excess (ABE) compare to anion gap in guiding sepsis treatment and ICU resource allocation?